HomePharma

Pharma

Pharma

FDA Accepts Takeda’s Zasocitinib NDA for Priority Review in Plaque Psoriasis

Life Sciences Times - 0
Pharma

FDA Grants Accelerated Approval to Bayer’s HYRNUO for First-Line HER2-Mutated Lung Cancer

Life Sciences Times - 0
Pharma

Takeda Reports Phase 3 Oveporexton Data Published in New England Journal of Medicine

Life Sciences Times - 0
Pharma

AstraZeneca Says Imfinzi-Tarlatamab Combination Improves Survival in Extensive-Stage Small Cell Lung Cancer

Life Sciences Times - 0
Pharma

Armata Pharmaceuticals Study Advances Understanding of Phage Biology

Life Sciences Times - 0
Pharma

Scholar Rock Gets FDA Fast Track Designation for Apitegromab in FSHD as Phase 2 Trial Begins

Life Sciences Times - 0
Pharma

AstraZeneca Completes Global Licensing Deal for Lung Cancer Drug ZEGFROVY

Life Sciences Times - 0
Pharma

Vertex Completes $10 Billion Acquisition of Crinetics, Expands Leadership Team

Life Sciences Times - 0
Pharma

Ascletis Doses First Participant in Global Phase 3 Program for Oral GLP-1 Drug ASC30

Life Sciences Times - 0
Pharma

Amgen Reports Repatha Reduced Risk of Death in High-Risk Patients Without Prior Heart Attack or Stroke

Life Sciences Times - 0
Pharma

Lilly Reports One-Year Phase 3b Data for Taltz and Zepbound in Psoriatic Disease and Obesity

Life Sciences Times - 0
Pharma

Karyopharm Submits FDA Application for XPOVIO Combination in Myelofibrosis

Life Sciences Times - 0
123...101Page 2 of 101

Most Read